Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Downgrades VistaGen Therapeutics to Hold

Maxim Group analyst Jason McCarthy downgrades VistaGen Therapeutics (NASDAQ:VTGN) from Buy to Hold.

July 26, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades VistaGen Therapeutics (NASDAQ:VTGN) from Buy to Hold.

How Much Would $1,000 Invested in Ethereum (ETH) Be Worth If It Returns To Merge-Day High

Today, 4:31 AM

Ethereum (CRYPTO: ETH) — the second-largest coin by market cap — has fallen 67.85% since the year began.

Today, 4:31 AM

Within the last quarter, Globe Life (NYSE:GL) has observed the following analyst ratings:

Today, 4:31 AM

SLING TV will become the first streaming company to offer a dedicated Barstool Sports channel in a move to grow its offerings of sports content.

Today, 4:31 AM

Amazon.com Inc (NASDAQ: AMZN) shares are beaten down and out of favor as the e-commerce giant prepares to report earnings after the bell.